H1N1 Vaccine Market - Forecast(2020 - 2025)

Report Code: HCR 0129 Report Format: PDF + Excel (Delivery in 48 Hrs)

H1N1 Vaccine Market Overview

H1N1 Vaccine Market size is forecast to reach $2.3 billion by 2025, growing at a CAGR of 4.51% during the forecast period 2020-2025. H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred to as swine flu. The H1N1 virus mainly affects the respiratory system including the nose, lungs, and throat of the infected person. Increasing incidences of epidemic H1N1 infection and declining immunity among the geriatric population are the major factors driving the growth of the market. Innovation in vaccine manufacturing to obtain universally acceptable vaccine for the H1N1 virus and increased awareness on H1N1 influenza is set to further enhance the overall market demand for H1N1 Vaccine Market during the forecast period 2020-2025.

H1N1 Vaccine Market Report Coverage

The report: “H1N1 Vaccine Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the H1N1 Vaccine Market. 
By Vaccine Type: Intranasal, Conjugate, Attenuated Vaccines, Inactivated Vaccines, Intramuscular, and Toxoid
By Type of Brand: Agripal, Fiuarix, Influgen, Influvac, Nasovac, Vaxigrip, and Others
By Geography: North America, Europe, Asia Pacific and Rest of the World (RoW)
 

Key Takeaways

  • North America dominated the H1N1 Vaccine Market in 2019 owing to the increasing initiatives for the prevention of H1N1 infection and technological advancements in the vaccine's presence of well-established healthcare infrastructure. The H1N1 Vaccine Market scope for different regions will be provided in the final report.
  • Rising vaccine manufacturing technologies and improved profitability for the industry are likely to aid in the market growth of the H1N1 Vaccine Market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the H1N1 Vaccine Market report.
  • Stringent regulatory rules and the absence of experienced medical professionals is poised to create hurdles for the H1N1 Vaccine Market.

H1N1 Vaccine Market Segment Analysis - By Vaccine Type

The Intramuscular held the largest share in the H1N1 Vaccine Market in 2019 and is estimated to grow at a CAGR of 5.19% during the forecast period 2020-2025. An intramuscular injection is a procedure used to deliver a medication deep into the muscles which allow the medication to be absorbed into the bloodstream quickly. Intramuscular injections are absorbed faster than subcutaneous injections owing to the fact that muscles have a greater blood supply than the tissue present under the skin. Moreover, muscle tissue can also hold a larger volume of medication than subcutaneous tissue. Intramuscular injections are a common practice in modern medicine. They’re used to deliver drugs and vaccines. Several drugs and almost all injectable vaccines are delivered this way. Intramuscular injections are used when other types of delivery methods aren’t recommended. Intramuscular injections are absorbed faster than subcutaneous injections since muscle tissue has a greater blood supply than the tissue just under the skin. Muscle tissue can also hold a larger volume of medication than subcutaneous tissue. Oral and Intramuscular vaccination has been considered to date as the ultimate way, but the nasal route offers advantages such as ease of self-administration and induction of mucosal as well as systemic immunity. Both liquid and dry powder formulations can be given via the intranasal route. Great consideration has to be given while selecting a suitable device for nasal administration since the volume delivered is very low. Several devices are available based on the number of doses to be administered and the type of dosage formulation Intramuscular is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.

H1N1 Vaccine Market Segment Analysis - By Geography 

North America dominated the H1N1 Vaccine Market in 2019 with a share of more than 38.97%, followed by the Asia Pacific owing to increasing awareness among the masses about the diseases coupled with growing government initiatives and programs to raise awareness among people about various infectious diseases. 
However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the discovery of new vaccines with greater efficiency, and advancements in the field of biomedical science. Increasing awareness among people about preventable diseases, the government launched programs to eradicate such infectious diseases and their causes, low wages to be paid to the workers, availability of a large talent pool and skilled personnel and less stringent environment and health safety regulations is also increasing the growth of the H1N1 vaccine market in this region.

H1N1 Vaccine Market Drivers

Increasing incidences of epidemic H1N1 infection and declining immunity among the geriatric population

Increasing incidences of epidemic H1N1 infection and declining immunity among the geriatric population is increasing the growth of the H1N1 Vaccine Market. Flu virus known as H1N1 is a combination of viruses from pigs, birds, and humans. H1N1 caused respiratory infection in humans that was commonly referred to as swine flu. Influenza virus causes acute upper and lower respiratory infections and is the most likely, among known pathogens, to cause a large epidemic in humans. The influenza virus mutates rapidly, enabling it to evade natural and vaccine-induced immunity. Furthermore, influenza viruses can cross from animals to humans, generating novel, potentially pandemic strains. Currently, available influenza vaccines induce a strain-specific response and might be ineffective against new influenza viruses. The difficulty in predicting circulating strains has frequently resulted in a mismatch between the annual vaccine and circulating viruses. Influenza viruses circulate globally and affect all age groups. Vaccines are the best tools available for preventing influenza illness. Thus, increasing the growth of the H1N1 Vaccine Market during the forecast period 2020-2025.

Innovation in vaccine manufacturing to obtain the universally acceptable vaccine for H1N1 virus and increased awareness on H1N1 influenza 

Innovation in vaccine manufacturing to obtain the universally acceptable vaccine for the H1N1 virus and increased awareness of H1N1 influenza is increasing the growth of the H1N1 Vaccine Market. Several new technologies and associated tools have the potential to revolutionize influenza surveillance and response activities. These include the increasingly routine use of whole-genome next-generation sequencing and other high-throughput approaches. Such approaches could not only become key elements in outbreak investigations but could drive a new surveillance paradigm. However, despite the advances made, significant challenges need to be addressed before next-generation technologies become routine, particularly in low-resource settings. Strengthening the vaccine virus selection process additionally requires the continuation of initiatives to improve the timeliness and representativeness of influenza viruses. Emerging approaches and techniques such as synthetic genomics, systems genetics, systems biology, and mathematical modelling are capable of generating potentially huge volumes of highly complex and diverse datasets. Growing awareness of influenza as an important global public health issue has been coupled to ever-increasing demands from the global community for more equitable access to effective and affordable influenza vaccines. The current influenza vaccine landscape continues to be dominated by egg-based inactivated and live attenuated vaccines, with a small number of cell-based and recombinant vaccines. Thus, increasing the growth of the H1N1 Vaccine Market during the forecast period 2020-2025.

H1N1 Vaccine Market Challenges

Stringent regulatory rules and the absence of experienced medical professionals 

Some of the factors that can impede the growth of the H1N1 Vaccine Market are stringent regulatory rules and the absence of experienced medical professionals. The high capital requirement, ample production to meet the population demand is set to create hurdles for the H1N1 vaccine market.

H1N1 Vaccine Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the H1N1 Vaccine Market. In 2019, the H1N1 Vaccine Market share is consolidated by the top ten players present in the market. H1N1 Vaccine, the top 10 companies are Abbott Laboratories, Pfizer, CPL Biologicals, Zydus Cadila, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Glaxosmith, Commonwealth Serum Laboratories, Sinobac, and Astra Zeneca Plc. among others.

Acquisitions/Product Launches

  • In April 2016, Abbott Laboratories acquired St. Jude Medical for $25Bn.

1. H1N1 Vaccine Market  - Overview
    1.1 Definitions and Scope
2. H1N1 Vaccine Market  - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by  Vaccine Type
    2.3 Key trends by Type of Brand
    2.4 Key trends by Geography
3. H1N1 Vaccine Market  – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. H1N1 Vaccine Market  - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. H1N1 Vaccine Market  – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. H1N1 Vaccine Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. H1N1 Vaccine Market  – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. H1N1 Vaccine Market   – By Vaccine Type (Market Size –$Million/$Billion)
    8.1 Intranasal
    8.2 Conjugate
    8.3 Attenuated Vaccines
    8.4 Inactivated  Vaccine
    8.5 Intramuscular
    8.6 Toxoid
    8.7 Others
9. H1N1 Vaccine Market   – By Type of Brand (Market Size –$Million/$Billion)
    9.1 Agripal
    9.2 Fiuarix
    9.3 Influgen
    9.4 Influvac 
    9.5 Nasovac
    9.6 Vaxigrip
    9.7 Other
10. H1N1 Vaccine Market  -  By Geography 
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada 
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Rest of Europe
    10.3 Asia Pacific  
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia
        10.3.6 New Zealand
        10.3.7 Rest of APAC
    10.4 Rest of the World
        10.4.1 Middle East
        10.4.2 Africa
        10.4.3 South America
11. H1N1 Vaccine Market  - Entropy
12. H1N1 Vaccine Market  – Industry/Segment Competition Landscape      Premium  
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. H1N1 Vaccine Market  – Key Company List by Country Premium  Premium
14. H1N1 Vaccine Market  Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

table 1: H1N1 Vaccine Market Overview 2019-2024
table 2: H1N1 Vaccine Market Leader Analysis 2018-2019 (US$)
table 3: H1N1 Vaccine Market Product Analysis 2018-2019 (US$)
table 4: H1N1 Vaccine Market End User Analysis 2018-2019 (US$)
table 5: H1N1 Vaccine Market Patent Analysis 2013-2018* (US$)
table 6: H1N1 Vaccine Market Financial Analysis 2018-2019 (US$)
table 7: H1N1 Vaccine Market Driver Analysis 2018-2019 (US$)
table 8: H1N1 Vaccine Market Challenges Analysis 2018-2019 (US$)
table 9: H1N1 Vaccine Market Constraint Analysis 2018-2019 (US$)
table 10: H1N1 Vaccine Market Supplier Bargaining Power Analysis 2018-2019 (US$)
table 11: H1N1 Vaccine Market Buyer Bargaining Power Analysis 2018-2019 (US$)
table 12: H1N1 Vaccine Market Threat of Substitutes Analysis 2018-2019 (US$)
table 13: H1N1 Vaccine Market Threat of New Entrants Analysis 2018-2019 (US$)
table 14: H1N1 Vaccine Market Degree of Competition Analysis 2018-2019 (US$)
table 15: H1N1 Vaccine Market Value Chain Analysis 2018-2019 (US$)
table 16: H1N1 Vaccine Market Pricing Analysis 2019-2024 (US$)
table 17: H1N1 Vaccine Market Opportunities Analysis 2019-2024 (US$)
table 18: H1N1 Vaccine Market Product Life Cycle Analysis 2019-2024 (US$)
table 19: H1N1 Vaccine Market Supplier Analysis 2018-2019 (US$)
table 20: H1N1 Vaccine Market Distributor Analysis 2018-2019 (US$)
table 21: H1N1 Vaccine Market Trend Analysis 2018-2019 (US$)
table 22: H1N1 Vaccine Market Size 2018 (US$)
table 23: H1N1 Vaccine Market Forecast Analysis 2019-2024 (US$)
table 24: H1N1 Vaccine Market Sales Forecast Analysis 2019-2024 (Units)
table 25: H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 26: H1N1 Vaccine Market By Type, Revenue & Volume, By Flu shot/ Inactivated Vaccine, 2019-2024 ($)
table 27: H1N1 Vaccine Market By Type, Revenue & Volume, By Nasal Spray/FluMist/Intranasal, 2019-2024 ($)
table 28: H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 29: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Agripal, 2019-2024 ($)
table 30: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Fiuarix, 2019-2024 ($)
table 31: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Influgen, 2019-2024 ($)
table 32: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Influvac, 2019-2024 ($)
table 33: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Nasovac, 2019-2024 ($)
table 34: North America H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 35: North America H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 36: South america H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 37: South america H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 38: Europe H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 39: Europe H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 40: APAC H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 41: APAC H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 42: Middle East & Africa H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 43: Middle East & Africa H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 44: Russia H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 45: Russia H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 46: Israel H1N1 Vaccine Market, Revenue & Volume, By Type, 2019-2024 ($)
table 47: Israel H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2019-2024 ($)
table 48: Top Companies 2018 (US$)H1N1 Vaccine Market, Revenue & Volume
table 49: Product Launch 2018-2019H1N1 Vaccine Market, Revenue & Volume
table 50: Mergers & Acquistions 2018-2019H1N1 Vaccine Market, Revenue & Volume


List of Figures

Figure 1: Overview of H1N1 Vaccine Market 2019-2024
Figure 2: Market Share Analysis for H1N1 Vaccine Market 2018 (US$)
Figure 3: Product Comparison in H1N1 Vaccine Market 2018-2019 (US$)
Figure 4: End User Profile for H1N1 Vaccine Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in H1N1 Vaccine Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in H1N1 Vaccine Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in H1N1 Vaccine Market 2018-2019
Figure 8: Ecosystem Analysis in H1N1 Vaccine Market 2018
Figure 9: Average Selling Price in H1N1 Vaccine Market 2019-2024
Figure 10: Top Opportunites in H1N1 Vaccine Market 2018-2019
Figure 11: Market Life Cycle Analysis in H1N1 Vaccine Market
Figure 12: GlobalBy TypeH1N1 Vaccine Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Type of Brand H1N1 Vaccine Market Revenue, 2019-2024 ($)
Figure 14: Global H1N1 Vaccine Market - By Geography
Figure 15: Global H1N1 Vaccine Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global H1N1 Vaccine Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 18: US H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 60: U.K H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 93: China H1N1 Vaccine Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)H1N1 Vaccine Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa H1N1 Vaccine Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel H1N1 Vaccine Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)H1N1 Vaccine Market
Figure 131: Developments, 2018-2019*H1N1 Vaccine Market
Figure 132: Company 1 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 H1N1 Vaccine Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 H1N1 Vaccine Market Net Sales Share, By Geography, 2018 (%)